Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

Drug Development

      FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

      Americas
      Johnson & Johnson said the U.S. Food and Drug Administration (FDA) has cleared DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for use as a single-agent treatment...

      FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

      Americas
      UCB, a leading global biopharmaceutical company, has announced that KYGEVVI has received FDA approval for the treatment of adults and pediatric patients diagnosed with...

      Lilly, NVIDIA Partner on AI Supercomputer for Drug Research

      Americas
      Eli Lilly and Company has revealed plans to construct what it calls the most powerful supercomputer ever built and operated by a pharmaceutical company,...

      FDA Unveils Initiative for Faster Biosimilar Development

      Americas
      The U.S. Food and Drug Administration (FDA) has unveiled a major initiative aimed at cutting both the time and cost required to develop biosimilar...

      Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

      Clinical Trials
      NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit Data showed consistent improvements across secondary outcome measures, and a favorable...

      AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN

      Drug Development
      Alexion, an AstraZeneca rare disease, has received EU approval for Koselugo (selumetinib), its oral, selective MEK inhibitor, to treat symptomatic, inoperable plexiform neurofibromas (PN)...

      Guardant Health, Zephyr AI Collab to Advance Cancer Research

      Drug Development
      Guardant Health and Zephyr AI have formed a strategic partnership to push forward the discovery of new cancer biomarkers and strengthen precision oncology efforts....

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.